je.st
news
Emergent BioSolutions Announces Pricing of Offering of $215 Million...
2014-01-24 09:36:10| Biotech - Topix.net
Emergent BioSolutions Inc. announced today the pricing of its offering of $215 million aggregate principal amount of 2.875% Convertible Senior Notes due 2021 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended , which was upsized from the previously announced $200 million ... (more)
Tags: million
offering
pricing
announces
Category:Biotechnology and Pharmaceuticals